Spots Global Cancer Trial Database for TJ202, Lenalidomide and Dexamethasone vs. Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: TJ202, Lenalidomide and Dexamethasone vs. Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
Official Title: A Phase 3, Randomized, Open-label, Parallel-controlled, Multi-center Study Comparing TJ202, Lenalidomide and Dexamethasone vs. Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma Who Received at Least 1 Prior Line of Treatment
Study ID: NCT03952091
Study Description
Brief Summary: A phase 3, randomized, open-label, parallel-controlled, multi-center study comparing TJ202, Lenalidomide and Dexamethasone vs. Lenalidomide and Dexamethasone in subjects with relapsed or refractory multiple myeloma who received at least 1 prior line of treatment
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Capital Medical University (CMU) - Beijing Chao-Yang Hospital, Beijing, Beijing, China
Peking University Third Hospital, Beijing, Beijing, China
Capital Medical University (CMU) - Beijing Chao-Yang Hospital, Beijing, Beijing, China
The First Affiliated Hospital of Bengbu Medical college, Bengbu, Bengbu, China
The First Bethune Hospital of Jilin University, Jilin, Changchun, China
Hunan Cancer Hospital, Hunan, Changsha, China
Fujian Medical University Union Hospital, Fujian, Fuzhou, China
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Sun Yat-Sen University Cancer Center, Guangdong, Guangzhou, China
Guangdong General Hospital, Guangdong, Guangzhou, China
Guangzhou First People's Hospital, Guangdong, Guangzhou, China
Nanfang Hospital, Guangdong, Guangzhou, China
The First Affiliated Hospital of Zhejiang University, Zhejiang, Hangzhou, China
The First Affiliated Hospital of Zhejiang University, Zhejiang, Hangzhou, China
Hubei Cancer Hospital, Wuhan, Hubei, China
Affiliated Hospital of Nantong University, Nantong, Jiangsu, China
Chang Gung Medical Foundation - Kaohsiung Chang Gung Memorial Hospital, Taiwan, Kaohsiung, China
The second affiliated hospital of Kunming medical university, Yunnan, Kunming, China
The First People's Hospital of Yunnan Province, Yunnan, Kunming, China
The First Hospital of Lanzhou University, Lanzhou, Lanzhou, China
Lanzhou University Second Hospital, Lanzhou, Lanzhou, China
Second Affiliated Hospital of Nanchang University, Jiangxi, Nanchang, China
Nanjing Drum Tower Hospital, Nanjing, Nanjing, China
Jiangsu Province Hospital, Nanjing, Nanjing, China
Guangxi Medical Univ. 1st Hospital, Guangxi, Nanning, China
Shanghai Changzheng Hospital, Shanghai, Shanghai, China
Shanghai Jiao Tong University School of Medicine - Ruijin Hospital, Shanghai, Shanghai, China
Shanghai Sixth People's Hospital, Shanghai, Shanghai, China
The First Hospital of China Medical University, Shenyang, Shenyang, China
Shenzhen Second Hospital, Guangdong, Shenzhen, China
The First Affiliated Hospital of Soochow University, Suzhou, Suzhou, China
National Taiwan University Hospital, Taiwan, Taibei, China
Taichung Veterans General Hospital, Taiwan, Taichung, China
Tri-Service General Hospital, Taiwan, Taipei, China
Tianjin Medical University General Hospital, Tianjin, Tianjin, China
Tianjin Cancer Hospital, Tianjin, Tianjin, China
The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, Wenzhou, China
The Central Hospital Of Wuhan, Hubei, Wuhan, China
Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Henan Cancer Hospital, Henan, Zhengzhou, China
Taipei Veterans General Hospital, Taipei, , Taiwan
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
